EDITEarnings•globenewswire•
Editas Medicine Announces Second Quarter 2025 Results and Business Updates
Sentiment:Negative (30)
Summary
Company to select lead development candidate in September; on track to file IND by mid-2026 and achieve human proof-of-concept by year-end 2026
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 12, 2025 by globenewswire